Literature DB >> 26599010

Identification of General and Heart-Specific miRNAs in Sheep (Ovis aries).

Alessandro Laganà1, Dario Veneziano1,2, Tyler Spata3, Richard Tang3, Hua Zhu3, Peter J Mohler4, Ahmet Kilic3.   

Abstract

MicroRNAs (miRNAs or miRs) are small regulatory RNAs crucial for modulation of signaling pathways in multiple organs. While the link between miRNAs and heart disease has grown more readily apparent over the past three years, these data are primarily limited to small animal models or cell-based systems. Here, we performed a high-throughput RNA sequencing (RNAseq) analysis of left ventricle and other tissue from a pre-clinical ovine model. We identified 172 novel miRNA precursors encoding a total of 264 mature miRNAs. Notably, 84 precursors were detected in both the left ventricle and other tissues. However, 10 precursors, encoding 11 mature sequences, were specific to the left ventricle. Moreover, the total 168 novel miRNA precursors included 22 non-conserved ovine-specific sequences. Our data identify and characterize novel miRNAs in the left ventricle of sheep, providing fundamental new information for our understanding of protein regulation in heart and other tissues.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26599010      PMCID: PMC4657999          DOI: 10.1371/journal.pone.0143313

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Coronary artery disease is the most common cause for mortality and development of heart failure in the United States [1-4]. Large animal models have been developed to study myocardial infarction with resultant ischemic heart failure [5-12]. The ovine model is particularly enticing in the study of heart failure due to its lack of collateral circulation, the resistance to fatal arrhythmias, and its anatomical similarities to humans [6,9,10,13]. However, the molecular mechanisms underlying development of heart failure in this critical pre-clinical model are unknown. In fact, we lack even a basic fundamental knowledge of the molecular pathways related to transcriptional and translational regulation in this species. miRNAs are small non-coding RNAs that act as post-transcriptional regulators of gene expression [14,15]. Their mature form (≅18÷22 nt long) is incorporated into a protein complex called RISC (RNA-induced silencing complex) to which they confer binding specificity to target mRNA molecules. miRNAs can bind their targets through partial or perfect complementarity and inhibit their translation or promote their degradation. Target recognition is often mediated by the seed region at the 5' end of the mature miRNA, although a supplementary or compensatory role of the central and 3' end of the miRNA has been observed [16]. miRNAs play a crucial role in many biological processes and their dysregulation is linked to a variety of diseases with significant impact in important cellular pathways [17-20]. Recently, miRNAs have been linked with heart failure, albeit primarily in a descriptive manner [21-23]. Several works have reported the discovery of ovine miRNAs and the latest version of miRBase (Release 21, June 2014) contains 106 precursors and 153 mature miRNAs [24-30]. However, there remains a paucity of data on the miRNAs in sheep cardiac tissue. The role of miRNAs in both diagnosis and treatment of heart failure remains enticing. Therefore, we defined and characterized novel miRNAs in the left ventricle of Ovis aries through high-throughput RNA sequencing (RNA-Seq) and a multi-step computational approach. Our results provide novel foundational work for understanding cardiac regulation in pre-clinical models by contributing to the characterization of the sheep “miRNAome”.

Materials and Methods

All studies were conducted with approval by the Institutional Animal Care and Use Committee (IACUC) at The Ohio State University (Study number: 2012A00000040). Adult male Dorset sheep weighing between 50–70 kg were used for this study (n = 5). Strict adherence was kept to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.

Tissue Harvesting and RNA isolation

All animals were sedated, and all attempts were made to minimize animal discomfort as previously described [31]. The animals underwent a 5th intercostal space left thoracotomy, and an expeditious cardiectomy was performed. Autologous platelets from sheep’s own blood were pre-spun to form platelet aggregates. Then, employing selective cardiac catheterization, these were injected into the left anterior descending artery to create a reproducible area of myocardial infarction. This did not necessarily produce ischemic heart failure as that is a chronic model (which requires weeks) and we were measuring the acute effects (3 days) of a myocardial infarction [5]. In addition, a laparotomy and craniotomy were performed with procurement of lung, liver, kidney, spleen, pancreas and brain tissue. The euthanization procedure strictly followed the Ohio State University IACUC approved method of euthanasia for vertebrate animals. In brief, the sheep were anesthetized using telazol 4–10 mg/kg and Isoflurane and intubated. After confirming the animals were under deep anesthesia (no response to deep tissue stimulus, lack of jaw tone, decreased respiration) the chest was opened to access the heart. The major vessels were cut to facilitate exsanguination and the heart and tissues removed for further analysis. The tissue was separated into two groups with the test group being left ventricular (LV) tissue and the control group being all others (Global Library). The tissue collected was immediately flash frozen in liquid nitrogen and stored in -80 C. RNA isolation was performed using the mirVana PARIS isolation kit (Ambion, Austin, Texas). RNA integrity was confirmed with agarose gel electrophoresis stained with ethidium bromide with a 28S:18S ratio ≥ 2.0 as confirmation of RNA integrity. The purity of RNA was confirmed via UV spectroscopy using A260 and A280 ratio.

Reverse transcription (RT) and preamplification

Reverse transcription and pre-amplification were performed according to the manufacturer’s instructions using TaqMan MicroRNA RT kit, Megaplex RT Primers, and Megaplex PreAmp Primers (Life Technologies Corporation, Carlsbad, CA). The mixture of total RNA with Megaplex RT primers, RNase Inhibitor and MultiScribe Reverse Transcriptase was reverse transcribed utilizing a C1000 thermal Cycler (Bio-Rad Laboratories Incorporated, Hercules, CA).

Illumina Deep Sequencing

Two small RNA libraries were generated from LV and global samples using the Illumina TruseqTM Small RNA Preparation kit according to Illumina’s TruSeqTM Small RNA Sample Preparation Guide [REF1]. The purified cDNA library was used for cluster generation on Illumina’s Cluster Station and then sequenced on Illumina GAIIx following vendor’s instruction for running the instrument. Raw sequencing reads (40 nts) were obtained using Illumina’s Sequencing Control Studio software version 2.8 (SCS v2.8) following real-time sequencing image analysis and base-calling by Illumina's Real-Time Analysis version 1.8.70 (RTA v1.8.70). The extracted sequencing reads were stored in file separate raw data files and were then used in the standard data analysis, which is described in the Results and in the Bioinformatics Methods sections.

Quantitative Stem-Loop Real-Time PCR

The expression of selected mature miRNAs in the LV sample was confirmed by Stem-Loop qRT-PCR performed with a TaqMan Human MicroRNA A array (version 2.0; Life Technologies Corporation, Carlsbad, CA) in association with TaqMan Universal Master Mix II (Life Technologies Corporation, Carlsbad, CA). The threshold cycle (Ct) = the fractional cycle number above a given threshold with normalization to U6 snRNA. The mean Ct of each sample was calculated as ΔCt with analysis via a commercially available software (SDS Relative Quantification Software, Applied Biosystems, Life Technologies Corporation, Carlsbad, CA). The relative quantification was solved with the equation of 2-ΔCt. The snRNA U6 was used as internal control. All microRNAs were considered expressed if Ct values were < 35. The conserved miRNAs were validated using TaqMan Assays for Ovis aries, where available, or 100% homologous miRNAs from other species (e.g. Bos taurus and Homo sapiens). The non-conserved miRNAs were validated using custom designed TaqMan Assays.

Bioinformatics Analysis

For each sample, raw sequence reads were extracted from image data and then processed by a proprietary pipeline script, ACGT101-miR v4.2 (LC Sciences), which employed a series of filter to remove various un-mappable sequencing reads [32,33]. Identical reads were clustered into unique families and stored in FastQ files, annotated with their copy numbers. In the subsequent filtering step, low-quality sequences due to sample preparation, sequencing chemistry and processes, and the optical digital resolution of the sequencer detector were removed. The remaining sequences, with lengths between 15 and 32 bases, were grouped by families of unique sequences and stored in FastQ files as mappable reads. The actual miRNA detection was carried out by applying miRDeep2, a software pipeline for the identification of miRNAs from deep sequencing data (https://www.mdc-berlin.de/rajewsky/miRDeep) [34]. miRDeep2 consists of a series of scripts which makes use of other software pieces such as the short read aligner Bowtie and the RNA secondary structure prediction tool RNA fold from the Vienna RNA package [35,36]. Briefly, the short reads are aligned to the genome, then all candidates whose structure and read signature are inconsistent with Drosha/Dicer processing are filtered out. Potential stem-loop precursors are assigned a score according to a Bayesian probabilistic model of miRNA biogenesis, which uses information such as the presence of a miRNA passenger strand, the presence of a conserved miRNA seed, and the absolute and relative energetic stability of the hairpin. The mappable reads FastQ files from LV and the global library were processed by miRDeep2 using the Ovis aries v3.1 genome reference sequence downloaded from NCBI (ftp://ftp.ncbi.nlm.nih.gov/genomes). For the prediction of novel miRNAs, we set a score cut-off threshold of 5, as it was the lowest score cut-off that yielded a signal-to-noise ratio higher than 10:1 (37:1), similarly to what has been described in other papers [37-40]. All the candidates with score below 5 were discarded. We didn’t employ the same filter for the detection of known miRNAs present in miRBase, as we considered their precursors already validated, but we filtered out all those candidates, novel and known, with mature read count below 10, this being a reasonable and commonly used count threshold [41-43]. All the candidates were processed by the miRBase, NCBI and RFam implementations of BLAST (miRBase: http://www.mirbase.org/search.shtml, NCBI: http://blast.ncbi.nlm.nih.gov/Blast.cgi, RFam: http://rfam.sanger.ac.uk/search), in order to assess their evolutionary conservation and filter out candidates that matched potential repetitive sequences and other types of short RNAs. The remaining candidates were further analyzed by employing ad-hoc scripts developed in the Ruby language (https://www.ruby-lang.org), in order to compute basic descriptive statistics about their genomic distribution, clustering and isomiRs, classify them into families, group multiple precursors encoding the same mature sequences and evaluate the dominant precursor arm in the different samples. The candidate mature miRNAs were processed by the software miRiam, in order to predict potential targets from the UCSC database of 3’ UTR sequences of the sheep (http://genome.ucsc.edu/) [44]. The lists of predicted targets were submitted to the online tool Ingenuity Pathway Analyzer (IPA), which we used to carry out the functional analysis.

Results and Discussion

Generation of RNA libraries from sheep and processing of sequencing data

To define the ovine miRNAome, we first generated a small-RNA library from sheep. Specifically, a small-RNA library was constructed from pooled RNA samples of nine tissues of adult male Dorset sheep (“global” sheep library; see Methods section for detailed approach). Moreover, to detect novel left ventricle specific miRNAs, a second small-RNA library (LV, “Left Ventricle specific” library) was generated from RNA samples obtained from the left ventricle of three adult male Dorset sheep. Illumina sequencing of the purified cDNA libraries generated 21,343,067 total raw reads: 9,512,054 from the LV library and 11,831,013 from the global library. Raw reads were processed by ACGT101-miR v4.2 (LC Sciences), a pipeline that employs a series of digital filters to remove unmappable reads [45,46]. Low-quality sequences, due to sample preparation, sequencing chemistry and processes, and the optical digital resolution of the sequencer detector, were removed. The remaining mappable sequences were grouped by unique families. A total of 5,537,088 and 9,089,864 mappable reads accounting for 58.2% and 76.8% of the total raw reads from LV and global libraries, respectively, were obtained. Fig 1 illustrates the length distribution of the total mappable reads, the majority of which were between 18 and 24 nt (90.93%).
Fig 1

Length distribution of the total mappable reads.

Processed high-quality sequences were analyzed by miRDeep2 [47,48], a computational tool to map, analyze and score deep sequencing data for the identification of known and novel miRNAs. Fig 2 illustrates an example of the miRDeep2 output. miRDeep2 mapped a total of 3,927,458 reads from the LV library (70.93% of the total count) and 6,663,266 reads from the global library (73.30% of the total counts) to a mature 5p or 3p miRNA sequence. Fig 3 illustrates the computational pipeline employed for data analysis (results described below). The raw data has been submitted to the NCBI SRA database (Project accession #: SRP038892; Samples accession # LV: SRR1175693, OT: SRR1175694). The original output generated by miRDeep2 is available as supporting information (S1 File).
Fig 2

An example of the miRDeep2 output.

The figure illustrates the output for the novel oar-miR-7134. The upper part shows the scores assigned to the miRNA, the reads count for the mature, star and loop sequences and the total count. The predicted secondary structure of the hairpin is also depicted, with the mature, star and loop sequences highlighted in different colors (red, purple and yellow, respectively). The bottom part of the figure shows all the reads associated to the miRNA, aligned to the mature, star and loop sequences of the predicted precursor on the genome (obs line) and the experimental sequence as reported in miRBase (exp line). For each sequence, the frequency (reads column) and mismatches with the genomic sequence (mm column) are given. The mismatches are also highlighted in capital letters. The different isomiRs, discussed in the Results and Discussion section, are extracted from this alignment data.

Fig 3

Computational pipeline of data analysis.

The figure illustrates the four steps of the computational pipeline employed to analyze the RNAseq data. Pre-Processing: raw data were processed by the ACGT101-miR v4.2 pipeline in order to obtain good quality mappable reads. miRNA detection/prediction: this step was carried out by applying miRDeep2 to the mappable reads. The tool returned the lists of known and novel miRNA precursors identified. Filtering: the output of miRDeep2 was further analyzed by BLAST against different databases in order to assess evolutionary conservation of the predicted miRNAs and remove sequences matching other kinds of small RNAs. Data Analysis: last step consisted of the application of a series of ad-hoc scripts for the extraction of descriptive statistics. The tool IPA was used to perform the functional enrichment analysis of the targets of the identified miRNAs, which were predicted by the software miRiam.

An example of the miRDeep2 output.

The figure illustrates the output for the novel oar-miR-7134. The upper part shows the scores assigned to the miRNA, the reads count for the mature, star and loop sequences and the total count. The predicted secondary structure of the hairpin is also depicted, with the mature, star and loop sequences highlighted in different colors (red, purple and yellow, respectively). The bottom part of the figure shows all the reads associated to the miRNA, aligned to the mature, star and loop sequences of the predicted precursor on the genome (obs line) and the experimental sequence as reported in miRBase (exp line). For each sequence, the frequency (reads column) and mismatches with the genomic sequence (mm column) are given. The mismatches are also highlighted in capital letters. The different isomiRs, discussed in the Results and Discussion section, are extracted from this alignment data.

Computational pipeline of data analysis.

The figure illustrates the four steps of the computational pipeline employed to analyze the RNAseq data. Pre-Processing: raw data were processed by the ACGT101-miR v4.2 pipeline in order to obtain good quality mappable reads. miRNA detection/prediction: this step was carried out by applying miRDeep2 to the mappable reads. The tool returned the lists of known and novel miRNA precursors identified. Filtering: the output of miRDeep2 was further analyzed by BLAST against different databases in order to assess evolutionary conservation of the predicted miRNAs and remove sequences matching other kinds of small RNAs. Data Analysis: last step consisted of the application of a series of ad-hoc scripts for the extraction of descriptive statistics. The tool IPA was used to perform the functional enrichment analysis of the targets of the identified miRNAs, which were predicted by the software miRiam.

Identification of Novel Sheep miRNAs

The miRDeep2 pipeline analysis identified 182 novel miRNA precursors, i.e. not previously reported in miRBase for sheep. A total of 1,607,604 reads from LV and 1,900,117 reads from the global library were mapped to novel miRNA candidates, accounting for 29% and 20.9% of the total mappable reads from LV and the global library, respectively.

Novel Sheep miRNAs: Conservation Analysis

We analyzed putative precursor sequences by miRBase implementation of BLAST to assess their evolutionary conservation and identify potential orthologs. 110 precursors exhibited a significant similarity match with precursors from at least 5 other species (EValue < 4e-09), 9 showed a significant similarity with <5 species (EValue < 9e-05) and one was comparable to a distant precursor from Drosophila pseudoobscura (miR-219) (EValue = 2e-18). Moreover, 29 stem-loop sequences had a significant match with precursors from the large Bos taurus miRNA family miR-2284/2285 (EValue < 2e-04). This family contains 101 precursors recently detected by deep sequencing of Bos taurus, encoding highly similar mature products [36,49,50]. These are the first example of miR-2284/2285 homolog miRNAs in a species other than Bos taurus. The remaining 33 precursors were further analyzed by BLAST against the Ovis aries genome and the Refseq-RNA and Rfam databases [51]. This analysis removed 10 candidates. Four of ten were removed because they had more than five significant hits against different chromosomal areas of the sheep genome (E < 2e-08), hence likely to be repeated sequences. The other 6 showed significant similarity with other small RNAs such as small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and transfer RNAs (tRNAs). We classified the remaining 24 sequences as novel sheep-specific miRNA precursors. The 172 conserved and non-conserved novel miRNA precursors encoded 262 unique novel 5p and 3p mature sequences (S1 Table). 84 precursors were detected in both LV and global samples, while 76 precursors were present in the global sample only, as opposed to 12 precursors which were instead specific to LV (Tables 1 and 2).
Table 1

Summary of novel sheep miRNAs.

SpecificityLV onlyGL onlyLV + GLTotal
Precursors 127684172
Mature 19115130264

The table contains a detailed summary of the novel miRNAs discovered. It shows the number of precursors, and relative mature sequences, found in the Left Ventricle library (LV), the Global Library (GL) or both libraries (LV + GL).

Table 2

Conservation of novel sheep miRNAs.

ConservationConserved > = 5 speciesConserved < 5 speciesConserved 1 speciesNon ConservedTotal
Precursors 112102921172
Mature 177164526264

The table shows the number of precursors, and relative mature sequences, which are non-conserved, conserved in more than five species, less than five species and in one species only. The latter include a distant homolog of miR-219 from Drosophila pseudoobscura, and the miRNAs of the miR-2284/2285 family from Bos taurus.

The table contains a detailed summary of the novel miRNAs discovered. It shows the number of precursors, and relative mature sequences, found in the Left Ventricle library (LV), the Global Library (GL) or both libraries (LV + GL). The table shows the number of precursors, and relative mature sequences, which are non-conserved, conserved in more than five species, less than five species and in one species only. The latter include a distant homolog of miR-219 from Drosophila pseudoobscura, and the miRNAs of the miR-2284/2285 family from Bos taurus.

Novel Sheep miRNAs: Arm Preference

Both arms of a miRNA precursor may give rise to functional levels of mature miRNA [15,52]. The dominant product may change from species to species and have different tissue expression preference, including normal versus pathological tissue [53-59]. Although 84 stem-loop sequences were detected in both samples, there were differences in the expression of their mature products. Notably, for 59 we detected the presence of the same mature sequences in both samples, as opposed to 25 precursors where the two samples differed in the presence of the corresponding mature products. For example, we detected both let-7e-5p and let-7e-3p in the global library, while only let-7e-5p was found in the LV library. Our data also showed that 86 out of 161 precursors found in global library (52.76%) and 51 out of 95 precursors found in LV (53.68%) expressed both 5p and 3p mature sequences at detectable levels (i.e. > 10 read counts). Moreover, 5p was the dominant product for more than half of the precursors in both LV (64.21%) and global library (53.98%), while only for five of 84 precursors a switch in arm preference between the two samples was observed. A single mature miRNA can derive from multiple precursors [24]. This represents a common feature, which is widespread across evolution. Our analysis found 13 pairs of precursors, six exclusively present in the global library, each encoding the same mature sequence.

Novel Sheep miRNAs: Nomenclature

Novel conserved miRNAs were named after their homologs in other species and assigned to their corresponding families, when possible (S1 Table). However, concerning the 29 precursors exhibiting significant similarity with the cow precursors belonging to the miR-2284/2285 family, the conservation analysis of their mature sequences returned multiple matches with members of the family. Therefore, such miRNAs were named after their closest matching mature sequences, taking specifically into account the seed area, when possible. In a few cases, we used the same name for highly similar sequences and added a progressive letter at the end (e.g. oar-miR-2285la and oar-miR-2285lb) (S1 Table). We identified 24 novel sheep-specific miRNA precursors. Three were detected in both LV and global library, three were specific to LV and the remaining 18 were only detected in the global library. We performed a BLAST analysis of their mature sequences against the miRBase database, to check if they were related to any known miRNA from other species. Despite no significant match of its precursor with any other stem-loop sequence in miRBase, one mature sequence shared some similarity, including six bases in the seed region, with miR-359-3p from Caenorhabditis briggsae, thus we decided to use the same nomenclature. No significant homology to any miRNA from any other species was identified for the 23 remaining sequences, thus we assigned them provisional names oar-miR-N1 to oar-miR-N22. Two of these precursors encoded the same mature sequence, oar-miR-N14-3p, therefore they were named with the same number followed by the additional numbers 1 and 2 (oar-miR-N14-1, oar-miR-N14-2), according to miRBase nomenclature rules [60]. Most of the 23 precursors gave rise to one mature product only, while four had both arms expressed. However, most of the 26 mature sequences encoded by these precursors had a rather low reads count. In particular, 22 sequences had less than 100 reads, three had a read count between 100 and 1000, while only one of them, that was detected in the LV sample only, had > 1000 reads (oar-miR-4005-5p) (S1 Table).

Identification of Known miRNAs in the Left Ventricle and Other Tissues

Our analysis also reported 100 known miRNA precursors from the global library encoding 159 mature sequences, 45 of which had not yet been reported in miRBase and were mostly non-dominant mature forms, i.e. the least expressed of the two mature products from a given precursor. Specifically, 85 out of 100 precursors were also detected in LV, encoding a total of 126 mature sequences (S2 Table). A total of 2,319,350 reads from LV and 4,762,811 reads from the global library were mapped to these miRNA mature sequences, accounting for 41.88% and 52.39% of the total mappable reads from LV and the global library, respectively. The analysis was not able to account for 70 and 53 known mature miRNAs from LV and the global library, respectively. This could be due to the very rapid turnover rates of some miRNAs or to their specificity to different tissues than the ones considered in this study.

Genomic Distribution

The novel miRNA precursors identified from our study were widely distributed throughout the genome with the exception of chromosome 8 where no miRNAs were located (Fig 4A). We discovered an average of 6.4 novel miRNAs/chromosome representing an ~3.5-fold increase in the number of miRNAs per chromosome (Fig 4B). The highest increase was of 6-fold on the X chromosome, where we identified 33 novel miRNAs, 26 of which were conserved in Bos taurus and other species on the X chromosome as well. Further, we discovered novel miRNAs on chromosomes 6, 7, 17, 20, 23, 25 and 26, where no miRNAs had been previously identified.
Fig 4

Genomic distribution of the identified miRNAs.

(a) The figure shows the chromosomal distribution of the novel (red) and known (blue) miRNAs. The known and novel clusters are represented by blue and red bars, respectively. (b) The stacked column chart shows the total number of miRNAs per chromosome, highlighting the fractions of known (blue) and novel (red) ones. We report miRNAs on chromosomes 6, 7, 17, 20, 23, 25 and 26 for the first time. (c) The chart shows the miRNA density per chromosome, calculated as the number of miRNAs per Mbp (Megabase pair).

Genomic distribution of the identified miRNAs.

(a) The figure shows the chromosomal distribution of the novel (red) and known (blue) miRNAs. The known and novel clusters are represented by blue and red bars, respectively. (b) The stacked column chart shows the total number of miRNAs per chromosome, highlighting the fractions of known (blue) and novel (red) ones. We report miRNAs on chromosomes 6, 7, 17, 20, 23, 25 and 26 for the first time. (c) The chart shows the miRNA density per chromosome, calculated as the number of miRNAs per Mbp (Megabase pair). Overall, chromosome 18 had both the highest number of miRNAs (60) and highest density (0.87), calculated as the number of miRNAs per Mbp (Fig 4C). Five of 60 miRNAs on chromosome 18 were discovered in this study. Chromosome 6, and 22 had the lowest number of miRNAs (two each) and the lowest densities (0.017 and 0.039, respectively), if we exclude chromosome 8.

Identification of Novel miRNA Clusters

A miRNA cluster is a group of precursors with an inter-miRNA distance of less than 10kb on the same genomic strand [24,61,62]. A miRNA cluster can be transcribed as a single polycistronic primary transcript and then processed into shorter pre-miRNAs to ultimately yield distinct mature miRNAs [63]. A simple analysis of the genomic locations of known sheep precursors recovered 10 clusters expressed in both samples and a large cluster spanning about 40 Kb on chromosome 18 containing 23 and 37 miRNA precursors expressed in LV and global library, respectively. Moreover, the genomic analysis of novel miRNAs identified 7 novel miRNA clusters containing 17 precursors encoding a total of 30 mature miRNAs. With the exception of one cluster consisting of two precursors of miR-2285m, from the miR-2284 family, the novel clusters were evolutionarily conserved. In particular, the cluster miR-452/miR-3431 was found in the cow genome, while the remaining five clusters were conserved in several species, including cow and human. Three of the novel discovered miRNAs, miR-18a, miR-20a and miR-92a, belonged to the miR-17/92 cluster on chromosome 10, joining miR-17 and miR-19b that were already reported in miRBase. The miR-17/92 is a well-studied conserved cluster consisting of six miRNAs [64-66]. miR-19a was the only miRNA of the conserved cluster that we did not detect and that is not reported in miRBase to date. Aside from the well-established oncogenic role played by the miRNAs of this cluster, miR-17-92 is implicated in both normal and pathological functions of the heart [66-68]. Specifically, the cluster regulates cardiomyocyte proliferation and dysregulation of this cluster during cardiovascular morphogenesis results in a lethal cardiomyopathy. Three of the remaining conserved clusters that we identified were located on sheep chromosome X as well as their homologs in human and cow. Moreover, miR-222, which we found expressed in LV, joined miR-221 which was already reported in miRBase, to form a conserved cluster also on chromosome X. Finally, we identified cluster mir-34b/c on chromosome 15 and mir-365a/193b on chromosome 24. The first was conserved in both human and cow, as well as in several other species, while the latter was conserved in human and gorilla only.

IsomiRs

A common feature of miRNAs is the presence of different variants of the same mature sequence, called isomiRs. RNA-Seq has allowed more detailed characterization of this phenomenon, once thought due to experimental artifacts. Evidence shows that isomiRs are functional variants with a specific biological role [69,70]. Indeed, they have been frequently observed in many species, tissues and conditions and recent studies have reported cases of functional isomiRs exhibiting significant overlapping targeting properties with their reference counterpart [71]. Although many types of variations have been observed, isomiRs can be classified into three main categories: 5’ isomiRs, 3’ isomiRs and polymorphic isomiRs. The first two categories consist of shifted sequences which can also differ in length from the reference sequence and can be sub-classified into templated and non-templated, depending on whether the additional nucleotides at the 5’ or 3’ end do or do not match the reference stem-loop sequence, respectively. These variants appear to be the most commonly observed, especially the templated 3’-shifted variants, and are likely to derive from imprecise Drosha and Dicer cleavage [69]. Polymorphic isomiRs are rarer isoforms which exhibit internal nucleotide substitutions and are probably caused by editing events, such as A-to-I editing, which is the most prevalent type of RNA editing so far [72,73]. Given the crucial role of the seed sequence on miRNA function, the most interesting isomiR forms are those affecting the seed region, such as the 5’-shifted isomiRs and the seed-edited isomiRs. The analysis of our miRNA reads showed a predominance of the reference form of mature miRNAs in both the LV and the global samples (60.48% in LV, 55.70% in global library) although a significant percentage was present for other forms as well. The most frequent isomiR type identified in our data was the templated 3’ isomiR (extended/truncated/shifted) (13.54% in LV, 20.34% in global library), followed by the non-templated 3’ isomiR (9.65% in LV, 11.05% in global library), the polymorphic isomiR (9.39% in LV, 8.29% in global library) and the templated 5’ isomiR (extended/truncated/shifted) (5.67% in LV, 3.47% in global library). Non-templated 5’ isomiRs as well as templated and non-templated forms extended or truncated at both 5’ and 3’ ends were rare (< 1.3% in LV, < 1.2% in global library). Fig 5A illustrates the distribution of the different types of isomiRs in both samples.
Fig 5

isomiRs distribution.

(a) The figure shows the distribution of the different types of isomiRs calculated on the total of mapped reads from both samples (LV and global library). The reference form was predominant (57.54%), while the most frequent isomiR types were the templated and non-templated (NT) 3’ isomiR and the polymorphic isomiR. (b) The predicted precursor structure for oar-miR-1a. (c) The mature and star sequences of miR-1a identified by miRDeep2. (d) The dominant mature product of miR-1a is encoded in the 3p arm (oar-miR-1a-3p). It is a 5' isomiR of the conserved miR-1-3p, which lacks the first nucleotide (human and cow sequences are reported for comparison).

isomiRs distribution.

(a) The figure shows the distribution of the different types of isomiRs calculated on the total of mapped reads from both samples (LV and global library). The reference form was predominant (57.54%), while the most frequent isomiR types were the templated and non-templated (NT) 3’ isomiR and the polymorphic isomiR. (b) The predicted precursor structure for oar-miR-1a. (c) The mature and star sequences of miR-1a identified by miRDeep2. (d) The dominant mature product of miR-1a is encoded in the 3p arm (oar-miR-1a-3p). It is a 5' isomiR of the conserved miR-1-3p, which lacks the first nucleotide (human and cow sequences are reported for comparison). For each novel identified conserved miRNA, the candidate mature products corresponded to either the miRBase reference versions or their 3’ isoforms, except for miR-1. Our analysis, indeed, detected 2 highly conserved precursors of miR-1 (EValue < 1e-18), for which the dominant mature product, as given rise by the 3p arm on both LV and global library, was a 5’-shifted isomiR of the conserved mature miR-1 (miR-1a-3p) (Fig 5B, 5C and 5D). In particular, this variant lacks the first nucleotide, thus affecting the seed area and, presumably, its targeting properties. We performed a functional analysis in order to investigate potential functional differences between our 5’-isomiR and its reference counterpart and the results are shown in the Analysis section.

Validation of known and novel miRNAs by Stem-Loop qRT-PCR

In order to validate the expression of the novel candidate miRNAs described in the previous sections, we selected 10 miRNAs and performed Stem-Loop qRT-PCR on RNA from the LV sample. Stem-Loop qRT-PCR is a reliable and widely used method for the detection and quantification of mature miRNAs [74]. In particular, we selected 5 miRNAs that were detected in both the LV and OT samples (oar-miR-145-5p, oar-miR-146b-5p, oar-miR-378-3p, oar-miR-423-5p and miR-145-5p) and 5 miRNAs specifically observed in the LV sample only, including a non-conserved miRNA (oar-miR-222-3p, oar-miR-330-3p, oar-miR-324-5p, oar-miR-2285x-3p and oar-miR-4005-5p). The experiment confirmed the expression of all 10 miRNAs in LV, as shown in Table 3, thus validating the RNA-Seq and computational analysis. We also successfully validated the expression of 4 known miRNAs in the LV sample (oar-miR-21, oar-miR-493-5p, oar-miR-494-3p, oar-miR-133-3p) (see Table 3). More details on the experimental procedure and the probes used are given in the Methods section.
Table 3

Validation of known and novel miRNAs by Stem-Loop qRT-PCR.

Novel miRNAs in LV
miRNA Ct Std Dev
miR-146b-5p33.1290.398256617
miR-151-5p26.2570.634608124
miR-378-3p20.9070.181923092
miR-423-5p29.1070.114140675
miR-145-5p27.7250.284937142
miR-222-3p30.5780.713898269
miR-330-3p30.8980.977237439
miR-324-5p26.1721.767929513
miR-2285x-3p28.1810.25621647
miR-4005-5p28.1810.25621647
U6 snRNA (control) 25.3380.144719684
Known miRNAs in LV
miRNA Ct Std Dev
miR-21-5p26.250.221885857
miR-493-5p34.250.41585374
miR-493-4p21.731.291861135
miR-133-3p14.442.278697632
U6 snRNA (control) 18.591.383107503

The experiments confirmed the expression of 10 novel and 4 known miRNAs in the left ventricle (LV). For each miRNA and the control U6, the table reports the threshold cycle (Ct) and the standard deviation (Std Dev).

The experiments confirmed the expression of 10 novel and 4 known miRNAs in the left ventricle (LV). For each miRNA and the control U6, the table reports the threshold cycle (Ct) and the standard deviation (Std Dev).

Analysis of Left-Ventricle Specific miRNAs

Our data allowed the discovery and characterization of novel miRNAs in the ovine left-ventricle and in other tissues. We primarily focused this study on microRNAs of sheep left ventricle, as this is the integral cardiac chamber involved in the development of heart failure. The ovine model has been an appropriate surrogate to study human heart failure, as it closely resembles the human heart in size, coronary anatomy as well as a predictable pattern of left ventricular remodeling following a myocardial infarction. As part of a larger project designed to look at both control tissue from a normal sheep heart and that of an infarcted, diseased heart, we sought to first create a roadmap of the normal miRNAome of the sheep–particularly the left ventricle. Further, our results recovered miRNAs that were already deposited in miRBase. Additional quantitative analysis will be necessary to assess significant differential expression of the detected miRNAs in the tissues examined [75]. However, large differences in the reads count of a miRNA between two different conditions may provide a meaningful estimate of its tissue-specificity [40]. We performed a simple fold-change analysis with the tool DESeq, that allows the analysis of RNA-Seq data from experiments without replicates [76]. Among the known miRNAs, miR-133a-3p, miR-22-3p and miR-26b, showed a much higher expression in LV compared to global library, in terms of normalized reads count (Fold Changes were 7.87, 4.29, and 4.07, respectively). These miRNAs were already known to be crucially involved in cardiac functions and diseases in human. In particular, miR-133 is typically enriched in cardiac and skeletal muscle and is involved in cell specification, differentiation and development [77]. Moreover, miR-133 has been proven to restrict injury-induced cardiomyocyte proliferation and its down-regulation is a prerequisite for the initiation of apoptosis, the development of fibrosis, and prolongation of the QT interval [77,78]. miR-22 and miR-26b had the second and third highest fold-changes. Recent studies showed that miR-22 functions as an integrator of Ca(2+) homeostasis and myofibrillar protein content during stress in the heart and that it has a role as a critical regulator of cardiomyocyte hypertrophy and cardiac remodeling [79,80]. miR-26b is known to be involved in cardiac hypertrophy as well, its down-regulation being required for the induction of pressure-induced cardiac hypertrophy [81]. A functional enrichment analysis of the predicted targets for miR-133a-3p, miR-22-3p and miR-26b performed by using the tool IPA (Ingenuity® Systems, www.ingenuity.com), indeed reflected their proven role in heart specific functions and diseases, being Cardiovascular Disease reported among the top 5 Diseases and Disorders (P < 0.01). In particular, the significantly associated terms included Myocardial Infarction (P < 0.0001), Ischemia of Heart (P < 0.001) and Proliferation of Cardiac Fibroblasts (P < 0.05). Cardiac Hypertrophy Signaling was reported among the pathways in which the three miRNAs could be significantly involved (P < 0.05), while the associated IPA toxicity list included terms such as Increases Cardiac Proliferation (P< 0.0001), Increases Cardiac Dilation (P< 0.01) and Cardiac Necrosis/Cell Death (P< 0.05). The most significant predicted targets involved in heart specific functions and diseases included IL6, ITGB2, PTGS1, PTGS2, ADRB3 and MAPK13 (see S3 Table). Our analysis also showed higher expression of miR-125b in LV compared to the global library. miR-125b is a known miRNA in sheep. A recent study demonstrated that the overexpression of this miRNA during human embryonic stem cell (hESC) differentiation into myocardial precursors and cardiomyocites (CM) results in the up-regulation of early cardiac transcription factors and accelerates progression of hESC-derived myocardial precursors to an embryonic CM phenotype [82]. Moreover, miR-125b was reported to protect the myocardium from ischaemia/reperfusion injury in mouse by preventing p53-mediated apoptotic signaling and suppressing TRAF6-mediated NF-kB activation [83]. Among the novel ovine miRNAs detected in our study, miR-208b showed higher expression in LV compared to the global library. miR-208b is a well known “myomiR” in human, that is, a muscle-specific miRNA, normally found highly expressed in cardiac tissue. This miRNA plays an important role in muscle growth due to its involvement in myogenesis and slow myosin heavy chain gene regulation [84,85]. The results of our analysis are also consistent with a recent work introducing the heart structure-specific transcriptomic atlas from rat, dog and monkey, where the authors identified, among others, miR-133a, miR-208b and miR-1 (which is discussed later in this section) as highly expressed in myocardial tissue, including the LV [86]. None of the 11 LV-specific miRNAs identified in our study was reported as heart-specific in human before. However, for two of them, miR-222 and miR-216b, a correlation with heart functions and disease was previously reported. One study found that miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling [87]. Another recent study reported that miR-221/222 contribute to the atherogenic calcification of vascular smooth muscle cells [88]. miR-216b was reported to be up-regulated in rat heart following treatment with Doxorubicin and preceding the rise of overt lesions, and may represent a valuable early genomic biomarker of drug-induced cardiac injury [89]. We performed a functional enrichment analysis of the predicted targets for the 11 LV-specific novel conserved and non-conserved miRNAs identified in our study, by using IPA. The results included Cardiovascular System Development and Function among the top 5 Physiological System Development and Function classes. In particular, the analysis identified 13 different function terms, including Vasculogenesis (P < 0.001), Activation And Permeability Of Microvascular Endothelial Cells (P < 0.01) and Chemotaxis Of Vascular Endothelial Cells (P < 0.001). Other significant terms associated to the LV-specific miRNAs included Heart Disease (P < 0.001), Apoptosis (P < 0.0001) and Apoptosis Of Vascular Endothelial Cells (P < 0.01). The associated IPA toxicity list included heart-specific terms such as Cardiac Hypertrophy (P < 0.05), Cardiac Hypertrophy Signaling (P < 0.05), Cardiac Fibrosis (P < 0.0001), Cardiac Necrosis/Cell Death (P < 0.05) and Increases Cardiac Dilation (P < 0.0001), while the significant tox functions included Myocardial Infarction (P < 0.01). The most significant predicted targets enriched in cardiovascular system functions and tox terms were ID3, PLAU, TIMP1, IL8, IL2RA, PTGS2, IFNG and SOD2 (S3 Table). Finally, we performed a functional analysis of miR-1-3p and its 5’ isomiR, oar-miR-1a-3p, the latter detected as the predominant mature form of miR-1 in both the LV and global samples. miR-1 is well known to play a key role in the development and physiology of muscle tissues including the heart. Interestingly, a recent paper reported a miR-1 polymorphic isomiR, different than the one identified in our study, significantly expressed in the heart left ventricle of the rat [90]. Therefore, we wanted to make some functional hypothesis on the potential biological roles of this newly discovered isomiR. The analysis reported both overlapping and specific targets for the two forms. In particular, genes such as AGTR1, ANKRD1, CAV2, IL13 and KDR, all predicted targets for the 5’ isomiR, were associated to the Cardiovascular System Development and Function network, which was reported among the 5 top scoring networks specific for the 5’-isomiR. Both mature forms shared Disease and Function terms such as Cardiovascular Disease (P < 0.0028), Organismal Injury and Abnormalities (P < 0.0028), Hematological System Development and Function (P < 0.0028) and Cellular Growth and Proliferation (P < 0.0028), while the isomiR was also specifically enriched in terms such as Cancer and Skeletal and Muscular Disorders (P < 0.003), and the IL-8 signaling pathway (P < 0.002) (S3 Table). Our analysis suggests potential heart-specific functions of this isomiR and encourage further experimental investigation, which we will undertake in the next phase of our project.

Conclusions

Our results define the miRNA signature of sheep left ventricle. Our findings validate previously discovered miRNAs, as well as identify novel miRNAs in heart. Further, our data provide new information on the identity of LV-specific miRNAs in sheep LV. We postulate that these findings will be crucial for our understanding of the molecular mechanisms of protein and cell regulation in this critical pre-clinical model.

miRDeep2 file.

The non-processed original miRDeep2 output. (ZIP) Click here for additional data file.

Novel miRNAs.

Details include reads count in the two samples, genomic coordinates, conservation, sequences and clusters. For each miRNA, the original miRDeep2 ID, matching the corresponding entry in S1 File, is provided. (XLSX) Click here for additional data file.

Known miRNAs.

Details include reads count in the two samples, genomic coordinates and sequences. For each miRNA, the original miRDeep2 ID, matching the corresponding file name, is provided. (XLSX) Click here for additional data file.

Functional Analysis computed by IPA.

(a) LV biological functions, (b) LV tox functions, (c) LV pathways, (d) LV networks, (e) LV toxicity lists, (f) miR-133a-3p, miR-22-3p and miR-26b biological functions, (g) miR-133a-3p, miR-22-3p and miR-26b tox functions, (h) miR-133a-3p, miR-22-3p and miR-26b pathways, (i) miR-133a-3p, miR-22-3p and miR-26b networks, (j) miR-133a-3p, miR-22-3p and miR-26b toxicity lists, (k) reference miR-1 biological functions, (l) reference miR-1 pathways, (m) reference miR-1 networks, (n) miR-1a biological functions, (o) miR-1a pathways, (p) miR-1a networks. (XLSX) Click here for additional data file.
  84 in total

1.  MicroRNA in the ovine mammary gland during early pregnancy: spatial and temporal expression of miR-21, miR-205, and miR-200.

Authors:  Laurent Galio; Stéphanie Droineau; Patrick Yeboah; Hania Boudiaf; Stephan Bouet; Sandrine Truchet; Eve Devinoy
Journal:  Physiol Genomics       Date:  2012-12-26       Impact factor: 3.107

2.  The role of microRNA-133 in cardiac hypertrophy uncovered.

Authors:  Maha Abdellatif
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

3.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Authors:  Ben Langmead; Cole Trapnell; Mihai Pop; Steven L Salzberg
Journal:  Genome Biol       Date:  2009-03-04       Impact factor: 13.583

4.  Genomic analysis of human microRNA transcripts.

Authors:  Harpreet Kaur Saini; Sam Griffiths-Jones; Anton James Enright
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

5.  Profiling of differentially expressed microRNA and the bioinformatic target gene analyses in bovine fast- and slow-type muscles by massively parallel sequencing.

Authors:  S Muroya; M Taniguchi; M Shibata; M Oe; K Ojima; I Nakajima; K Chikuni
Journal:  J Anim Sci       Date:  2012-10-16       Impact factor: 3.159

Review 6.  Large animal models of heart failure: a critical link in the translation of basic science to clinical practice.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  Circ Heart Fail       Date:  2009-05       Impact factor: 8.790

7.  Perturbation of microRNAs in rat heart during chronic doxorubicin treatment.

Authors:  Caterina Vacchi-Suzzi; Yasmina Bauer; Brian R Berridge; Sandrine Bongiovanni; Kevin Gerrish; Hisham K Hamadeh; Martin Letzkus; Jonathan Lyon; Jonathan Moggs; Richard S Paules; François Pognan; Frank Staedtler; Martin P Vidgeon-Hart; Olivier Grenet; Philippe Couttet
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

8.  Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions.

Authors:  Caterina Vacchi-Suzzi; Florian Hahne; Philippe Scheubel; Magali Marcellin; Valerie Dubost; Magdalena Westphal; Catherine Boeglen; Stine Büchmann-Møller; Ming Sin Cheung; André Cordier; Christopher De Benedetto; Mark Deurinck; Moritz Frei; Pierre Moulin; Edward Oakeley; Olivier Grenet; Armelle Grevot; Robert Stull; Diethilde Theil; Jonathan G Moggs; Estelle Marrer; Philippe Couttet
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

9.  A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.

Authors:  Eva van Rooij; Daniel Quiat; Brett A Johnson; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Robert J Kelm; Eric N Olson
Journal:  Dev Cell       Date:  2009-11       Impact factor: 13.417

Review 10.  Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling.

Authors:  Dmitry A Chistiakov; Igor A Sobenin; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

View more
  9 in total

1.  Identification and expression analysis of conserved microRNAs during short and prolonged chromium stress in rice (Oryza sativa).

Authors:  Sonali Dubey; Sharad Saxena; Abhishek Singh Chauhan; Priyanka Mathur; Vibha Rani; Debasis Chakrabaroty
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-02       Impact factor: 4.223

2.  Discovery and characterization of the feline miRNAome.

Authors:  Alessandro Laganà; Wessel P Dirksen; Wachiraphan Supsavhad; Ayse Selen Yilmaz; Hatice G Ozer; James D Feller; Kiersten A Vala; Carlo M Croce; Thomas J Rosol
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

3.  Identification of novel microRNAs in the sheep heart and their regulation in heart failure.

Authors:  Lee Lee Wong; Miriam T Rademaker; Eng Leng Saw; Kar Sheng Lew; Leigh J Ellmers; Christopher J Charles; Arthur Mark Richards; Peipei Wang
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

4.  Regulation of FSH expression by differentially expressed miR-186-5p in rat anterior adenohypophyseal cells.

Authors:  Dong-Xu Han; Yue Xiao; Chang-Jiang Wang; Hao Jiang; Yan Gao; Bao Yuan; Jia-Bao Zhang
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240

5.  MicroRNA Expression Profile in Peripheral Blood Lymphocytes of Sheep Vaccinated with Nigeria 75/1 Peste Des Petits Ruminants Virus.

Authors:  Yang Yang; Xiaodong Qin; Xuelian Meng; Xueliang Zhu; Xiangle Zhang; Yanmin Li; Zhidong Zhang
Journal:  Viruses       Date:  2019-11-05       Impact factor: 5.048

6.  Differential expression of novel MicroRNAs from developing fetal heart of Gallus gallus domesticus implies a role in cardiac development.

Authors:  Sharad Saxena; Priyanka Mathur; Vaibhav Shukla; Vibha Rani
Journal:  Mol Cell Biochem       Date:  2019-09-07       Impact factor: 3.396

7.  Cardioprotective Effect of Crocin Combined with Voluntary Exercise in Rat: Role of Mir-126 and Mir-210 in Heart Angiogenesis.

Authors:  Vajihe Ghorbanzadeh; Mustafa Mohammadi; Hassan Dariushnejad; Alireza Abhari; Leila Chodari; Gisou Mohaddes
Journal:  Arq Bras Cardiol       Date:  2017-06-29       Impact factor: 2.000

8.  Identification and characterization of microRNAs in the intestinal tissues of sheep (Ovis aries).

Authors:  Lei Hou; Zhibin Ji; Guizhi Wang; Jin Wang; Tianle Chao; Jianmin Wang
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

9.  Identification of Ovine Serum miRNAs Following Bacterial Lipopolysaccharide Challenge.

Authors:  Ankita Sharma; Umesh K Shandilya; Tianna Sullivan; Danielle Naylor; Angela Canovas; Bonnie A Mallard; Niel A Karrow
Journal:  Int J Mol Sci       Date:  2020-10-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.